vs

Side-by-side financial comparison of INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

INNOVATIVE INDUSTRIAL PROPERTIES INC is the larger business by last-quarter revenue ($66.7M vs $40.7M, roughly 1.6× PETMED EXPRESS INC). INNOVATIVE INDUSTRIAL PROPERTIES INC runs the higher net margin — 47.8% vs -26.0%, a 73.7% gap on every dollar of revenue. On growth, INNOVATIVE INDUSTRIAL PROPERTIES INC posted the faster year-over-year revenue change (-13.1% vs -23.3%). Over the past eight quarters, INNOVATIVE INDUSTRIAL PROPERTIES INC's revenue compounded faster (-6.0% CAGR vs -20.9%).

Oxford Properties is a Canadian multinational corporation, with operations in real estate investment, development and property management. Its portfolio includes office, retail, industrial, multi-residential, life sciences and hotel assets. Established privately in 1960 and later wholly owned by the Ontario Municipal Employees Retirement System (OMERS) since 2003, the company is headquartered in Toronto with regional head offices in New York City, London, Australia, Singapore and Luxembourg. ...

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

IIPR vs PETS — Head-to-Head

Bigger by revenue
IIPR
IIPR
1.6× larger
IIPR
$66.7M
$40.7M
PETS
Growing faster (revenue YoY)
IIPR
IIPR
+10.1% gap
IIPR
-13.1%
-23.3%
PETS
Higher net margin
IIPR
IIPR
73.7% more per $
IIPR
47.8%
-26.0%
PETS
Faster 2-yr revenue CAGR
IIPR
IIPR
Annualised
IIPR
-6.0%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IIPR
IIPR
PETS
PETS
Revenue
$66.7M
$40.7M
Net Profit
$31.8M
$-10.6M
Gross Margin
23.3%
Operating Margin
47.8%
-25.7%
Net Margin
47.8%
-26.0%
Revenue YoY
-13.1%
-23.3%
Net Profit YoY
-20.4%
-1392.6%
EPS (diluted)
$1.07
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIPR
IIPR
PETS
PETS
Q4 25
$66.7M
$40.7M
Q3 25
$64.7M
$44.4M
Q2 25
$62.9M
$51.2M
Q1 25
$71.7M
$50.8M
Q4 24
$76.7M
$52.0M
Q3 24
$76.5M
$58.0M
Q2 24
$79.8M
$66.2M
Q1 24
$75.5M
$65.1M
Net Profit
IIPR
IIPR
PETS
PETS
Q4 25
$31.8M
$-10.6M
Q3 25
$29.3M
$-8.5M
Q2 25
$26.0M
$-34.2M
Q1 25
$31.1M
$-11.6M
Q4 24
$40.0M
$-707.0K
Q3 24
$40.2M
$2.3M
Q2 24
$42.0M
$3.8M
Q1 24
$39.4M
$-5.0M
Gross Margin
IIPR
IIPR
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
IIPR
IIPR
PETS
PETS
Q4 25
47.8%
-25.7%
Q3 25
45.5%
-18.9%
Q2 25
45.9%
-66.7%
Q1 25
47.4%
-11.9%
Q4 24
54.7%
-0.9%
Q3 24
54.8%
1.0%
Q2 24
53.1%
6.6%
Q1 24
55.7%
-5.9%
Net Margin
IIPR
IIPR
PETS
PETS
Q4 25
47.8%
-26.0%
Q3 25
45.3%
-19.2%
Q2 25
41.4%
-66.7%
Q1 25
43.3%
-22.9%
Q4 24
52.2%
-1.4%
Q3 24
52.6%
4.0%
Q2 24
52.6%
5.7%
Q1 24
52.3%
-7.7%
EPS (diluted)
IIPR
IIPR
PETS
PETS
Q4 25
$1.07
$-0.50
Q3 25
$0.97
$-0.41
Q2 25
$0.86
$-1.65
Q1 25
$1.03
$-0.56
Q4 24
$1.35
$-0.03
Q3 24
$1.37
$0.11
Q2 24
$1.44
$0.18
Q1 24
$1.36
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIPR
IIPR
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$47.6M
$26.9M
Total DebtLower is stronger
$393.7M
Stockholders' EquityBook value
$1.8B
$32.8M
Total Assets
$2.4B
$88.0M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIPR
IIPR
PETS
PETS
Q4 25
$47.6M
$26.9M
Q3 25
$41.9M
$36.1M
Q2 25
$104.9M
$41.1M
Q1 25
$133.3M
$54.7M
Q4 24
$151.2M
$50.1M
Q3 24
$172.4M
$52.0M
Q2 24
$160.9M
$46.0M
Q1 24
$173.5M
$55.3M
Total Debt
IIPR
IIPR
PETS
PETS
Q4 25
$393.7M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IIPR
IIPR
PETS
PETS
Q4 25
$1.8B
$32.8M
Q3 25
$1.9B
$43.1M
Q2 25
$1.9B
$51.5M
Q1 25
$1.9B
$85.1M
Q4 24
$1.9B
$96.2M
Q3 24
$1.9B
$96.4M
Q2 24
$1.9B
$93.5M
Q1 24
$2.0B
$96.7M
Total Assets
IIPR
IIPR
PETS
PETS
Q4 25
$2.4B
$88.0M
Q3 25
$2.3B
$100.3M
Q2 25
$2.3B
$109.8M
Q1 25
$2.4B
$148.7M
Q4 24
$2.4B
$144.8M
Q3 24
$2.4B
$146.0M
Q2 24
$2.4B
$152.7M
Q1 24
$2.4B
$169.9M
Debt / Equity
IIPR
IIPR
PETS
PETS
Q4 25
0.21×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIPR
IIPR
PETS
PETS
Operating Cash FlowLast quarter
$198.2M
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
6.22×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIPR
IIPR
PETS
PETS
Q4 25
$198.2M
$-9.2M
Q3 25
$45.6M
$-2.2M
Q2 25
$48.4M
$-12.3M
Q1 25
$54.2M
$7.0M
Q4 24
$258.4M
$-1.2M
Q3 24
$64.9M
$7.4M
Q2 24
$64.2M
$-8.5M
Q1 24
$71.6M
$7.1M
Free Cash Flow
IIPR
IIPR
PETS
PETS
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
IIPR
IIPR
PETS
PETS
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
IIPR
IIPR
PETS
PETS
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
2.2%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
IIPR
IIPR
PETS
PETS
Q4 25
6.22×
Q3 25
1.56×
Q2 25
1.86×
Q1 25
1.75×
Q4 24
6.46×
Q3 24
1.61×
3.18×
Q2 24
1.53×
-2.27×
Q1 24
1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIPR
IIPR

Segment breakdown not available.

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons